Improved Dual-Luciferase Reporter Assays for Nuclear Receptors by Paguio, Aileen et al.
  Current Chemical Genomics, 2010, 4, 43-49 43 
 
  1875-3973/10  2010 Bentham Open 
Open Access 
Improved Dual-Luciferase Reporter Assays for Nuclear Receptors  
Aileen Paguio, Pete Stecha, Keith V. Wood and Frank Fan* 
Promega Corporation, Madison, Wisconsin, USA 
Abstract: Nuclear receptors play important roles in many cellular functions through control of gene transcription. It is 
also a large target class for drug discovery. Luciferase reporter assays are frequently used to study nuclear receptor func-
tion because of their wide dynamic range, low endogenous activity, and ease of use. Recent improvements of luciferase 
genes and vectors have further enhanced their utilities. Here we applied these improvements to two reporter formats for 
studying nuclear receptors. The first assay contains a Murine Mammary Tumor Virus promoter upstream of a destabilized 
luciferase. The presence of response elements for nuclear hormone receptor in this promoter allows the studies of endoge-
nous and/or exogenous full length receptors. The second assay contains a ligand binding domain (LBD) of a nuclear re-
ceptor fused to the GAL4 DNA binding domain (DBD) on one vector and multiple Gal4 Upstream Activator Sequences 
(UAS) upstream of luciferase reporter on another vector. We showed that codon optimization of luciferase reporter genes 
increased expression levels in conjunction with the incorporation of protein destabilizing sequences into luciferase led to a 
larger assay dynamic range in both formats. The optimum number of UAS to generate the best response was determined. 
The expression vector for nuclear receptor LBD/GAL4 DBD fusion also constitutively expresses a Renilla luciferase-neo
R 
fusion protein, which provides selection capability (G418 resistance, neo
R) as well as an internal control (Renilla lu-
ciferase). This dual-luciferase format allowed detecting compound cytotoxicity or off-target change in expression during 
drug screening, therefore improved data quality. These luciferase reporter assays provided better research and drug dis-
covery tools for studying the functions of full length nuclear receptors and ligand binding domains. 
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INTRODUCTION 
  The Nuclear Hormone Receptor (NHR) superfamily in-
cludes receptors for steroids, retinoids, thyroid hormone and 
vitamin D. These receptors are ligand-inducible transcription 
factors that regulate the expression of target genes involved 
in development, cell differentiation, and organ physiology 
[1]. Steroid hormones, since their first isolation in 1927, 
have been the targets of many drugs and the research of ster-
oid receptors have advanced the treatment of cancer, osteo-
porosis, and endocrine and reproductive disorders [2]. The 
induction of steroid hormone pathways has also been in-
creasingly important in the study of off-target drug effects 
and environmental toxicology [3]. 
  NHRs have two major structural features, a highly con-
served DNA binding domain (DBD), that targets the receptor 
to a specific DNA sequence upstream of a target gene, the 
hormone responsive element, and a C-terminal conserved 
ligand binding domain (LBD), which is involved in dimeri-
zation of the receptor and transactivation of target genes.  
  Reporter gene assays are uniquely suited to studying 
NHR because activating gene expression is a direct result of 
its action. In particular, luciferase reporter assays are fre-
quently used because of their wide dynamic range, low en-
dogenous activity, and ease of use [2, 4]. Recent improve-
ments of luciferase genes and vectors represented by the 
pGL4 vector series have further enhanced the utilities of   
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reporter assays for research and drug discovery. Most nota-
bly, codon optimization of luciferase reporter genes has in-
creased expression levels and the incorporation of PEST- 
amino acid sequences that signal the protein for degradation 
by the proteosome- into luciferase has led to a larger assay 
dynamic range up to several hundred-fold [5, 6]. 
  Two reporter formats are commonly utilized for assaying 
nuclear receptor function (Fig. 1). The first assay format 
incorporates a response element known to induce expression 
of target genes upstream of a reporter gene. This format en-
ables the study of full length endogenous or exogenous re-
ceptors. Transfection of the response element and reporter 
gene into a cell line containing the endogenous receptor of 
interest has the advantage of analyzing the receptor signaling 
pathway in a native biological context. However, signal in-
duction from endogenous receptors can be low. In addition, 
multiple receptors are known to bind to the same response 
element, which can complicate data interpretation. To im-
prove assay quality, receptors can be introduced into the cell 
exogenously. In this case, the receptor is commonly ex-
pressed from a strong viral promoter such as Cytomegalovi-
rus or SV40 promoter for high levels of expression. The 
MMTV promoter contains hormone response elements that 
are known to stimulate the androgen (AR), mineralcorticoid 
(MR), Glucocorticoid (GR), and progesterone receptors (PR) 
and has been used successfully in drug discovery compound 
screening and profiling [2, 7, 8]. The second assay format 
utilizes the ligand binding domain of a nuclear receptor 
fused to the GAL4 DNA binding domain on one vector and 
multiple GAL4 Upstream Activator Sequences (UAS) up-
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ligand binding and transactivation. The advantages of this 
format include low cross-reactivity with other nuclear recep-
tors and the fact that the chimeric receptor is generally less 
toxic to the cells when overexpressed [2, 4]. Often, research-
ers will use both assay formats. For example, during drug 
discovery, the GAL4 hybrid system is frequently used to 
screen compounds for agonist or antagonist hit identification. 
The response element- luciferase reporter assay in a biologi-
cally relevant cell line is then used for hit to lead verification 
during secondary screening. 
  In this report, we applied the advancement of luciferase 
gene, vector and genetic engineering to current assays to 
create better tools for studying nuclear receptor research and 
drug discovery.  
MATERIALS AND METHODOLOGY 
Chemicals  
 17- estradiol (E2), estrone, ICI 182,780, tamoxifen, 
raloxifene, dihydrotestosterone (DHT), dexamethasone 
(Dex), hydrocortisone (HC), aldosterone, RU486, progester-
one, prednisone, were purchased from Sigma Chemical 
Company (St. Louis, MO). 
Plasmid Construction 
  Either 5 or 9 copies of the GAL4 UAS was inserted into 
pGL4.15[luc2P /Hygro] or pGL4.14 [luc2/Hygro] (Promega, 
Madison, WI), by PCR, utilizing the Acc65I and HindIII 
restriction enzyme sites and standard molecular cloning tech-
niques. The clone containing 9 copies of the GAL4 UAS was 
was named pGL4.35[luc2P/9XGAL4UAS/Hygro]. A DNA 
sequence of ER-LBD (amino acids 303-595; Genbank 
NM_000125) was synthesized by DNA 2.0 (Menlo Park, 
CA), and cloned into pFN26A (BIND) hRluc-neo (Promega) 
by SgfI/PmeI so that the SgfI site yields an in-frame protein 
fusion with GAL4-DBD. A DNA sequence of GR-LBD 
(amino acids 500-777; Genbank NM_000176) was synthe-
sized and cloned into pFN26A (BIND) hRluc-neo by the 
same method as ER. These constructs were named pBIND-
ER and pBIND-GR respectively. The MMTV promoter 
(GenBank: U13861.1) was synthesized and cloned into 
pGL4.15 [luc2P/Hygro] and pGL4.14 [luc2/Hygro] using 
two SfiI sites each with unique internal sequences, yielding 
unique 3’ overhangs for unidirectional ligation. Full length 
AR (Genbank: NM_000044) driven by the CMV promoter 
was purchased from Origene (Rockville, MD). Constructions 
were verified by restriction digest and sequencing. One 
amino acid difference relative to the Genbank sequence 
(amino acid 240 of Genbank sequence) was introduced in the 
ER-LBD by accident. It led to significantly increased in-
duction (100- Fold) and right shifted the EC50’s of agonists 
(supplementary material Fig. 1), but did not affect potency 
ranking (data not shown). 
Cell Culture and Generation of GloResponse™ 
9XGAL4UAS-luc2P HEK293 Cell Line 
  HEK293 cells were cultured in DMEM (Invitrogen, 
Carlsbad CA) supplemented with 10% fetal bovine serum at 
37
oC with a humidified atmosphere at 5% CO2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Reporter gene assay formats. A) A response element upstream of the reporter gene is induced by full length endogenous receptor 
or a receptor that is exogenously introduced. Upon ligand binding and activation by the ligand the nuclear receptor binds to the response 
element to activate transcription. B) The GAL4 hybrid format utilizes two plasmids. One contains a number of GAL4 UAS repeats upstream 
of the reporter gene. The second plasmid contains the LBD of the receptor of interest fused to the GAL4 DBD. Upon ligand binding the 
GAL4 DBD-NR-LBD fusion binds to the GAL4 UAS to activate transcription. 
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  A stable cell line containing 9XGAL4UAS-luc2P was 
generated by lipid transfection of HEK293 with pGL4.35 
luc2P/9XGAL4UAS/Hygro]. 2 x 10
6 cells were seeded in a 
10 cm dish. The next day plasmid DNA was transfected us-
ing TransIT
®-LT1 Transfection Reagent (Mirus Bio, Madi-
son WI) following manufacturer’s protocol. A hygromycin 
resistant population was selected at 500g/ml after two 
weeks. Clones were isolated by limiting dilution plating in 
96-well plates. Individual clones were ranked by level of 
activation of ER by E2 or GR by dex after transient transfec-
tion of the receptor. The best clone was the clone with the 
highest induction of ER and GR and above background basal 
luciferase expression, which was subsequently named the 
GloResponse™ 9XGAL4UAS-luc2P HEK293 Cell Line.  
Luciferase Reporter Assays 
  96-wells assays were performed by seeding 10,000 cell/ 
well and transeintly transfecting pGL4.35 luc2P/9XGAL4 
UAS/Hygro] and pBIND-ER or pBIND-GR. For assays in 
the GloResponse
TM 9XGAL4UAS-luc2P, either the pBIND-
ER or pBIND-GR was transfected. 20-24 hours after trans-
fection cells were treated with agonist or mock treated. 
  For assays in 384-well plates, cells were first seeded at 2 
million cells/ 10 cm dish and transfected. 20-24 hours later, 
cells were transferred to 384-well plates containing com-
pound at 10,000 cells/well, 20 l per well. 
  For GR antagonist assays, each antagonist was serially 
diluted and added to cells in the presence of 100 nM Dex. 
For ER antagonist assays, the antagonist was serially diluted 
and added to cells in the presence of 1.0 nM E2. 
  Transfected cells were assayed 20-24 hours post- treat-
ment with Dual-Glo
® Luciferase Assay System (Promega, 
Madison WI). Assays in 96-wells plates were read with the 
Turner Biosystems (Sunnyvale, CA) GloMax
® 96 Microplate 
Luminometer, 0.5 second integration/ well. Assays in 384-
well plates were read with the Thermo Fisher Scientific 
(Waltham, MA) VarioSkan multimode reader, 0.5 second 
integration/well. 
  Inductions were calculated as the relative light units of 
the treated sample/ average relative light units of the un-
treated samples and plotted against the log of the compound 
concentration using Prism 4 software (GraphPad Software, 
San Diego CA). The sigmoidal does-response equation with 
varying slope was used to fit the data to generate the EC50 or 
IC50 values. Z’ values were calculated using the following 
formula: Z´= 1–[(3*SDtreatd + 3*SDuntreated)/ (averagetreated –
averageuntreated)]. 
RESULTS AND DISCUSSION 
Destabilized Luciferase Enhances Assay Performance  
  The codon optimized luciferase, luc2 and a version of the 
luc2 gene containing the PEST protein degradation se-
quence, luc2P, were compared in the two reporter formats. 
MMTV promoter contains multiple copies of a hormone 
response element, which is known to induce several NHR’s. 
We tested this MMTV promoter- luciferase construct for 
activation of two different receptors, an exogoneously ex-
pressed androgen receptor and an endogenously expressed 
glucocorticoid receptor. The activation of an exogenously 
introduced androgen receptor by DHT was compared with 
MMTV promoter driving either luc2 or luc2P. HEK293 cells 
were transiently co-transfected with pGL4.36[luc2P/MMTV/ 
hygro] or the same vector with luc2 and a plasmid express-
ing the full length androgen receptor (AR) driven by the 
CMV promoter. Titrating amounts of DHT were added to 
cells. Luciferase expression was induced 140-fold with an 
EC50 of 7.9 nM for the luc2P gene whereas the luc2 gene 
was only induced 64-fold, with an EC50= 9.9 nM. The pres-
ence of the PEST degradations sequence improves the dy-
namic range. A negative control of pGL4.36 [luc2P/MMTv/ 
hygro] co-transfected with pUC19 shows no induction (Fig. 
2A). HeLa, which express endogenous glucocorticoid recep-
tor were transiently transfected with pGL4.36 
[luc2P/MMTV/hygro] or the same vector with luc2. Cells 
were induced with titrating amounts of dex. In this case, the 
difference between the two genes was minor, around 20% 
greater induction with luc2P (data not shown). To demon-
strate the expected potency ranking, dex and HC were ti-
       A          B  
 
 
 
 
 
 
 
 
 
 
Fig. (2).  MMTV promoter is activated by multiple full length receptors.  A) HEK293 were transiently transfected with 
pGL4.36[MMTV/luc2P/hygro] or the MMTV promoter driving luc2 and vector containing a CMV driven full length AR. For a negative 
control, pGL4.36[MMTV/luc2P/hygro] was co-transfected with pUC19 vector. Cells were then induced with 1:5 dilutions of Dihydro-
testosterone (DHT). B) HeLa cells were transiently transfected with pGL4.36[MMTV/luc2P/hygro] in 96-well plates, then induced with 1:4 
serial dilutions of hydrocortisone or dexamethasone.  46    Current Chemical Genomics, 2010, Volume 4  Paguio et al. 
trated and added to cells after transfecting with 
pGL4.36[luc2P/MMTV/hygro]. Luciferase expression was 
induced 35-fold with dex and 28-fold with HC (Fig. 2B) 
which is in agreement with published literature [9].  
  Using the GAL4 hybrid format, luc2 and luc2P gene 
were compared for reporter dynamics with either the estro-
gen receptor alpha (ER) LBD or the glucocorticoid receptor 
(GR) LBD fused to the GAL4 DBD. HEK293 cells were 
transiently co-transfected with each combination. With the 
ER-LBD, the expression from the luc2 gene was 170-fold 
over that of untreated. The luc2P gene induced with E2 ex-
pressed 270- fold over untreated. The Rapid Response luc2P 
had a 1.7-fold increased induction over luc2 for ER. With the 
GR-LBD induced with dex, the luc2 gene was induced 30-
fold over untreated and the luc2P gene induced 62-fold over 
untreated cells. This corresponds to a 2.3 fold increased re-
sponse of luc2P compared to luc2 at 24 hours post ligand 
exposure (Fig. 3A).  
  Utilizing destabilized reporters to better reflect transcrip-
tional dynamics have been reported with several popular 
reporters including luciferase and green fluorescent protein 
[10, 11]. The basic rationale for this approach is that destabi-
lized reporters have lower steady-state levels so that changes 
in the promoter activities can be quickly represented. We 
have compared the performance of destabilized luciferase to 
its regular counterpart in several biological systems includ-
ing GPCR induction (Fig. 6 in ref. [5]), nuclear receptor 
studies as shown in this report and pathway analysis (manu-
script in preparation). In general, the improved dynamic is 
observed. In time course experiments, destabilized lu-
ciferases often reach highest induction at earlier time points 
and gives higher maximum signal to background ratio over 
native luciferase. However, the details vary case by case, 
perhaps due to the complexity of each model system.  
Increased GAL4 UAS Repeats Enhances Assay Perform-
ance 
  We tested 5 to 10 copies of the GAL4 Upstream Activa-
tor Sequence (UAS) and found that increasing the number of 
UAS up to 9 copies also increased induction response with 
the ER-LBD in the pG5luc (Promega) backbone by around 
1.5 fold (data not shown). We then transferred either 5 or 9 
copies of the GAL4 UAS to the pGL4 backbone with luc2P 
and co-transfected with pBIND-ER. Nine copies of the 
GAL4 UAS also increased the induction response in the 
pGL4 vector backbone, 310-fold for 5X compared to 490- 
fold for 9X, or an increase of 1.7- fold (Fig. 3B). When 
combined, these two elements, nine copies of the GAL4 
UAS and use of the destabilized and codon optimized, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Improved reporter dynamics in the GAL4 hybrid format. HEK293 cells were transiently transfected with vectors in 96-well 
plates. E2 was used to induce ER; dex was used to induce GR. Cells were harvested 24 hours post induction and assayed for luciferase activ-
ity with Dual-Glo
TM Assay System. Luminescence was measured on the GloMax luminometer. Induction = treated Fluc RLU/average un-
treated Fluc RLU. A) Vectors containing either 5X Gal4 UAS- luc2 or luc2P were transfected. Each reporter was co-transfected with either 
ER-LBD or GR-LBD. B) Vectors containing either 5X GAL4 UAS-luc2P or 9X GAL4 UAS-luc2P were transfected. Each reporter was co-
transfected with ER-LBD fused to the GAL4 DBD. C & D) Vectors containing either 5X UAS-luc2 or the 9XUAS-luc2P vectors and either 
GR or ER-LBD vectors. 1:3 serial dilutions of each compound were added to the wells.  
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luc2P, contribute to a 5-fold increase in induction with ER 
and 2.2-fold increase with GR. The EC50’s were not 
changed. For ER, 5XUAS-luc2 the EC50 was 6.2 nM and 6.7 
nM for 9XUAS-luc2P. For GR, the EC50’s were 6.5 nM and 
17 nM for 5XUAS-luc2 and 9XUAS-luc2P  respectively 
(Figs. 3C and D).  
Improved Luciferase Nuclear Receptor Assays for Drug 
Discovery 
 The  GloResponse
TM 9XGAL4UASluc2P HEK293 cell 
line was transiently transfected with either pBIND-ER or 
pBIND-GR and were evaluated for their performance in high 
throughput screening (HTS) assays by determining the Z´-
factor value for an agonist assay in 384-well plate format. 
The ER assay induced with E2 had a Z’ of 0.8 and the GR 
assay had a Z’ of 0.79 when induced with dex. These Z´-
factor values significantly higher than 0.5, an acceptance 
criterion commonly used for high-throughput screening [12]. 
These assays also maintained a Z’ greater than 0.5 in the 
presence of up to 1% DMSO or ETOH (data not shown).  
  To evaluate the compound specificity of the GAL4 hy-
brid assay the EC50 and IC50 of known agonists and antago-
nist for the estrogen receptor and glucocorticoid receptor 
were determined. Fig. (4A) shows the EC50 generated in the 
GAL4 hybrid format for GR agonists. The potency rankings 
for GR agonists were dex<HC<aldosterone. The IC50’s for 
GR antagonists ranked as follows (Fig. 4B): RU486   
<Progesterone<Prednisone. Both results are in agreement 
with published literature [9]. The rank order potency for ER 
agonists of E2<estrone<DHT is comparable with other 
transactivation assays (Fig. 4C; [8, 9]). The rank order po-
tency for ER antagonist in this format was ICI,182,780 
<raloxifene< tamoxifen (Fig. 4D). The IC50 for ICI 182,780 
was 10 nM and raloxifene, 47 nM in our tests. Published 
literature for other transactivation or binding assays show 
these two antagonists to have IC50’s within one log, but re-
ports conflict as to their ranking [9, 13-15]. Our results are 
consistent with the similarity of the IC50’s. This similarity 
may cause alternating rankings depending on assay and cell 
type. Table 1 summarizes the EC50’s, IC50’s and induc-
tions. 
Dual Luciferase Format Improves Data Quality 
  The expression vector for nuclear receptor LBD/GAL4 
DBD fusion (pFN26A (BIND) hRluc-neo) also constitu-
tively expresses a Renilla  (Rluc) luciferase-neo
R fusion, 
which can be used for selection (neo
R) of stable clones as 
well as an internal control reporter (Renilla luciferase). We 
observed a reduction in firefly (Fluc) stimulation at high E2 
concentrations. To determine if this drop is caused by cyto-
toxicity of the compound and if the Renilla reporter could be 
used to detect compound cytotoxicity or any other off-target 
change in expression in a dual luciferase assay, HEK293 
cells were transiently co-transfected in 96-well plates with 
pBIND-ER-LBD and pGL4.35 [luc2P/9XGAL4UAS/  
Hygro] vectors and treated with titrated concentrations of 
E2. Firefly and Renilla luciferase activities were measured 
using the Dual-Glo™ Assay System. Another plate was pre-
pared in parallel and measured with CellTiter-Glo
® Lumi-
nescent Cell Viability Assay. Fig. (5) shows that at highest 
Fig. (4). Compound Ranking. A) 9XGAL4UAS stable cell line was transiently transfected with pBIND-GR and then transferred to 384 well 
plates. One day after transfection, cells were induced with a serial dilution of agonists. B) Antagonists were serially diluted and added to cells 
in the presence of 100 nM Dex. C) 9XGAL4UAS stable cell line was transiently transfected with pBIND-ER. One day after transfection, 
cells were induced with a serial dilution of agonists. D) Antagonists were serially diluted and added to cells in the presence of 1.0 nM E2. 48    Current Chemical Genomics, 2010, Volume 4  Paguio et al. 
concentrations of E2, the expression of the Firefly reporter 
still shows induction of 50 fold over basal, though reduce 
from a peak of 250-fold. The Renilla reporter is not induced 
(induction around 1.0) by E2. However, for the three highest 
concentrations of E2, Renilla expression drops below basal, 
resulting in declining induction ratios from 1.0 to 0.5. De-
creasing cells viability at these three highest points of E2 is 
verified by decreasing values in the CellTiter-Glo
® Lumines-
cent Cell Viability Assay, paralleling the Renilla reporter 
expression. In one assay, the Dual-Glo™ Assay System, two 
results can be obtained—the primary firefly reporter expres-
sion and a second control reporter Renilla reporter, which 
can detect off-target signal perturbations and cytotoxicity. 
  Dual luciferase system has been widely used to study 
promoters and transcriptional response elements. In that ap-
plication, firefly luciferase is used as functional reporter and 
Renilla as a control reporter to normalize transfection effi-
ciency. For the application in HTS, Renilla luciferase can be 
used as an internal control to detect cytotoxicity, therefore 
improving data quality by identifying potential false hit as 
shown in this report. However, since Fluc and Rluc are unre-
lated enzymes, it will not be able to detect false hits due to 
the interference (inhibition or activation) with Fluc. In that 
aspect, a green and red click beetle luciferases system offers 
advantages since the two reporters are essentially the same 
except difference in emission spectrum rendered by several 
amino acids in the active site. With the appropriate instru-
ment and data analysis, the click beetle system showed great 
utilities in HTS as demonstrated by Davis et al. [16]. Alter-
natively,  Renilla luciferase can be used as a second func-
tional reporter to detect another cellular event. The signal 
strength of Renilla luciferase can be adjusted depend on 
which constitutive promoter (e.g. CMV, SV40, TK) was 
chosen to drive Rluc expression.  
CONCLUSION 
  We have described improved reporter performance in 
two reporter formats for assaying nuclear receptors by utiliz-
ing the codon optimized and destablized Rapid Response 
luciferase reporter gene, luc2P in the pGL4 vector backbone. 
The MMTV promoter driving luc2P is a single reporter that 
can be used to assay several different full length NR’s, en-
dogenous or exogenously expressed. In the GAL4 hybrid 
format, nine copies of the GAL4 UAS and the luc2P gene 
both improved the dynamic range of the response to appro-
priate stimuli. The improved dynamic range in both these 
reporter formats will improve their use for high-throughput 
screening or profiling. 
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Table 1.  Potency  Ranking.  GloResponse 9XGAL4-luc2P 
HEK293 cell line was transiently transfected with vec-
tor containing receptor LBD in a 10-cm dish. The day 
after transfection, cells were transferred to 384-well 
plates and a titration of each compound was added to 
cells. The fold-induction was plotted using GraphPad 
Prism 4 software. The EC50/IC50 was determined from 
the sigmoidal dose-response equation with varying 
slope which fit the data. A) ER was tranfected. B) 
pBIND-GR was transfected 
A) ER 
Agonist EC50 (nM)  Induction 
17-estradiol (primary ligand)  0.025  2200 
Estrone 7.2  900 
Dihydro-testosterone 8500  630 
Antagonist IC50 (nM)   
Tamoxifen 2000   
ICI 182,780 10   
Raloxifene 47   
 
B) GR 
Agonist EC50 (nM)  Induction 
Dexamethasone (primary ligand)  7.4  760 
Hydrocortisone 520  450 
aldosterone 21000  42 
Antagonist IC50 (nM)   
RU486 5.8   
Progesterone 77   
Prednisone 27000   
 
 
 
 
 
 
 
 
 
 
Fig. (5). Renilla reporter expression parallels compound cyto-
toxicity. High concentrations of E2 have an effect on cell viability. 
HEK293 cells were transiently co-transfected in 96-well plates with 
ER-LBD/ 5X luc2P vectors. 24 hours post transfection, 1:2 serial 
dilutions of E2 was added to the respective wells. An another plate 
was prepared in parallel and measured with CellTiter-Glo
® Lumi-
nescent Cell Viability Assay. Firefly and Renilla luciferase activi-
ties were measured using the Dual-Glo™ Assay System. Firefly 
reporter expression (Fluc), Renilla reporter expression (Rluc) and 
CellTiter-Glo
® Luminescent Cell Viability Assay Luminescence 
(cytotoxicity) shown as induction, ave. treated/ave. untreated.  
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